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Vesicoureteral reﬂux is uncommonly diagnosed and treated after puberty. The natural history of uncorrected VUR after puberty
is not documented. Postpubertal patients with recurrent pyelonephritis and VUR should be considered for treatment. Ureteral
reimplantation, endoscopic injections, and laparoscopic or robotic ureteral reimplantation may be utilized. Endoscopic injection
is an appealing option for these patients. The role of laparoscopic or robotic ureteral reimplantation in these patients is evolving.
Copyright © 2008 J. Christopher Austin. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
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1. INTRODUCTION
Vesicoureteral reﬂux (VUR) is a common ﬁnding in children
with urinary tract infections (UTIs). The incidence of
VUR associated with UTIs drops signiﬁcantly in older
children, particularly after the age of 5 [1]. It has been
a long-held dogma of pediatric urology that unresolved
VUR should be treated before a child progresses through
puberty. There is concern that females with uncorrected
VUR will have problems with pyelonephritis when they
become sexuallyactive and during pregnancy. Pyelonephritis
during pregnancy increases the risks of the pregnancy and
possibly to the unborn child as well. If these children have
their reﬂux corrected before they go through puberty, these
problems could be prevented. While in theory this justiﬁes
the surgical correction of all children who fail to resolve their
reﬂux during a period of observation, there is little evidence
to support treating all children and no long-term studies
documenting the natural history of uncorrected VUR after
puberty. This manuscript will review the association of VUR
and UTIs in patients treated after puberty and examine the
role, nuances, and outcomes of treating VUR after puberty.
2. CLINICAL IMPORTANCE OF VUR AFTER PUBERTY
There has been a long-standing observation of the associa-
tion of febrile UTIs and the development of renal scarring
[2]. The riskiest time for the development of renal scarring
due to febrile UTI associated with primary VUR is infancy
and the risk of developing new scars drops signiﬁcantly after
age of 5 [3]. It is still common to follow and treat patients
beyond this age. While severe scarring may predispose to
chronic kidney disease in a small percentage (estimated at
2%), the majority of children with VUR are not at signiﬁcant
risk for renal failure [4]. There is a higher incidence of
hypertension in patients with renal scarring, but severe
complications due to VUR are unusual. The only reliable
beneﬁt to patients who’s VUR is surgically corrected is
a decreased risk of pyelonephritis, but the incidence of
UTIs is similar to those who reﬂux has persisted. These
ﬁndings have led some to consider stopping antibiotic
prophylaxis in selected children and ceasing surveillance for
resolution [5, 6]. Voiding cystourethrograms (VCUG) can
be perceived as traumatic by children and simplifying their
follow-up and avoiding these tests may be a major factor
in discontinuing follow-up for some parents. As a result
of these practices more and more physicians are going to
allow children with persistent VUR to continue through
puberty with uncorrected VUR. As a group, these patients
will likely have lower grades of VUR, infrequent UTIs, and
normal renal function. There are currently no longitudinal
studies documenting just what risks these patients will
face and whether their VUR will be a signiﬁcant problem
during adolescences and adulthood. It is likely that some of
these patients will have future problems with UTIs and be
considered for treatment of their VUR after puberty.
There has also been a change in VUR management
by some pediatric urologists that is the polar opposite of2 Advances in Urology
stopping prophylaxis and observing patients. Instead of
following patients for resolution of their VUR, primary
therapy with endoscopic injections after the diagnosis of
VUR is being oﬀered [7]. Touted as a minimally invasive
alternative, the “15-minute cure” is being used as upfront
therapy in patients after diagnosis to avoid the need to
prolonged antibiotic prophylaxis and prolonged follow-up
while waiting for the VUR to resolve. While success rates
greater than 90% are reported by experienced surgeons, the
follow-upintheseseriesisgenerallyshortwithVCUGsbeing
performed usually within 3 months of the procedure [8].
There is a known rate of relapse for this method which is
highest for collagen, and was reported to be greater than
50% at 5 years [9]. The relapse rate is lower for other
agents [10, 11]. If there is a 10–15% relapse over 5–10
years (a reasonable estimate given the few long-term studies
available) it is likely that there will be increasing numbers of
late failures of endoscopic therapy. Of these patients, some
will present after puberty with pyelonephritis and recurrent
VUR.
3. VUR AND UTIs AFTER PUBERTY
The primary motivation for treatment of VUR before
puberty has been over concerns of increased risk of UTIs
when female patients become sexually active or pregnant.
To my knowledge, however, the natural history of women
with persistent VUR during pregnancy has not been docu-
mented. Pyelonephritis is a known risk to pregnant women
and strongly associated with bacteruria. Large series have
r e p o r t e dr a t e so f2 %o fp r e g n a n tw o m e n[ 12]. In pregnant
women with a history of VUR or surgically corrected VUR,
higher rates of UTIs and pyelonephritis have been reported.
Mansﬁeldetal.reportedcomplicationsduringpregnancyfor
patients who had undergone surgical correction of VUR and
a group with a history of VUR that did not undergo surgery
[13] .T h er a t eo fc y s t i t i sa n dp y e l o n e p h r i t i sw a s2 2 %a n d
18%, respectively, during pregnancy for the patients with
surgically corrected VUR. These rates were higher than the
patients without treatment of their VUR with cystitis in 15%
and pyelonephritis in 1.5%. They also reported a high rate of
UTIs with the onset of sexual activity in 75% of patients with
surgically treated VUR and 62% of those with a history of
VUR that was not treated. There is a signiﬁcantly increased
risk ofUTIsinwomenwithahistoryofVUR.Therecouldbe
multiple explanations for the diﬀerences in the two groups
including that the surgical procedure is the cause of the
increased UTIs. Due to the retrospective nature however,
the authors point out that this observation of higher rates
of UTIs in the surgically treated patients does not prove
that the problem is due to the surgery. Other factors may
be responsible for these diﬀerences, such as selection bias.
These patients likely had an increased susceptibility to UTIs,
whichislikelywhatpushedthemtosurgicalcorrectioninthe
ﬁrst place. The authors recommend that pregnant women
with a history of ureteral reimplantation surgery undergo
frequent screening for bacteruria during pregnancy and
that prophylactic antibiotics be considered in these patients.
Other series of long-term follow-up of patients with VUR
treated with ureteral reimplantation surgery have similar
ﬁndings. Beetz et al. reported a 25-year follow up in 158
patients [14]. Female patients reported subsequent UTIs in
74% after surgery versus 10% of males. 17% developed UTIs
during pregnancy, however, they did not report whether
these patients had pyelonephritis or cystitis. Of the UTIs,
most (66%) were afebrile versus preoperatively where the
UTIswerefebrile.Itremainsunknownastowhetherpatients
experiencing continued problems with UTIs after surgery
would have fewer problems if they had not undergone
surgery.
4. WHICH PATIENTS SHOULD BE
EVALUATED AND TREATED?
The incidence of VUR after puberty is signiﬁcantly lower
than in young infants with febrile UTIs [1]. It has been well
established that VUR is a risk factor for pyelonephritis and
that it frequently is present as one of several risk factors
for UTIs. Voiding dysfunction must always be considered
in this patient population and treated appropriately. With
proper treatment and modiﬁcation of risk factors such as
infrequent voiding, dysfunctional voiding, constipation, and
incomplete emptying the VUR may be eliminated without
surgical treatment [15].
Most postpubertal patients with VUR will present with
UTIs. Since the majority of patients will not have VUR
and assuming that VUR is an important risk factor for
pyelonephritis, what are the factors that should prompt an
evaluation for VUR in a postpubertal patient? First and
foremost should be a history of recurrent febrile urinary
tract infections, as these patients if found to have reﬂux,
have a good chance of having their symptoms alleviated
if VUR is found and treated. Suspicion should be raised
if there is a history of prior VUR, febrile infections as a
young child, or a family history of VUR. Due to the high
association of renal scarring and VUR, patients who have
a history of recurrent febrile UTIs and evidence of renal
scarring on imaging studies should be evaluated for VUR. To
evaluate for VUR a standard VUCG may be performed, or
if there are symptoms worrisome for voiding dysfunction a
videourodynamics study. In patients with evidence of renal
scarring or a small kidney on ultrasound, a DMSA renal
scan should be obtained to evaluate for renal scarring and
the diﬀerential function. Typically, the grade of VUR is
an important factor for predicting resolution and risk of
renal scarring; however, in postpubertal patients it has not
been studied as extensively. It is expected that the rates of
spontaneous resolution will be lower after puberty.
5. SURGICAL TREATMENT OF VUR AFTER PUBERTY
One of the more humbling experiences for a pediatric urol-
ogist is their ﬁrst ureteral reimplantation done on a female
after puberty. These diﬃculties start as females approach
puberty. During puberty, the pelvis widens and deepens
in the female. The trigone assumes a deeper retropubic
location which makes access to the ureteral oriﬁces and the
mobilization of the ureters more diﬃcult. Additionally, theJ. Christopher Austin 3
plexus of vein running across the surface of the bladder
enlarge and are more prone to troublesome bleeding during
ureteral dissection. Though not well documented, most
pediatric urologists would agree that, if a child truly needed
ureteral reimplantation for correction of their VUR, then the
operation is best performed if they are operated on during
childhood rather than after puberty. Experience would tell
us that they recover quicker and that technically the surgery
should be more successful, however, there are not series
documenting poorer results after ureteral reimplantation
for patients treated after puberty. Options for treatment
of VUR in patients after puberty include intra- or extra-
vesical ureteral reimplantation, endoscopic injection, and
laparoscopic or robotic reimplantation. In patients with
unilateral VUR to a poorly functioning kidney nephrectomy
may be an alternative choice to ureteral reimplantation. This
can be performed laparoscopically with rapid recovery and
short hospitalization.
6. URETERAL REIMPLANTATION
As mentioned previously, the postpubertal changes in
women make the surgical access to the trigone more chal-
lenging and limit exposure; however, ureteral reimplantation
can be performed in women successfully. In males, the
changes are less dramatic. Published results of ureteral
reimplantation in postpubertal patients are sparse due to the
limitednumberofpatientsinwhomthissurgeryisindicated.
From a technical standpoint, it is prudent to position the
patient over the break in the OR table. This allows the table
to be ﬂexed if necessary to open the pelvis and improve
retropubic exposure. This is similar to the positioning of
a male undergoing radical retropubic prostatectomy. The
size and body mass index will play a role with obese
patients creating more diﬃculties with exposure. Proper
surgical planning and the use of larger and more ﬂexible
ﬁxed retractors such as a Bookwalter rather than the Denis-
Browne retractor will facilitate the procedure. Both ureteral
advancements and ureteroneocystotomy procedures (e.g.,
Cohen, Glenn-Anderson, and Politano-Leadbetter) can be
performed but limited data is available on their use in the
treatment of VUR postpuberty [16–20] .T h e r eh a v eb e e n
reports of the use of trigonoplasty (Gil-Vernet) procedures,
which in postpubertal patients oﬀer the advantage of less
dissection and mobilization [21, 22] .S u c c e s sr a t e so fu pt o
97% have been reported but follow-up is limited to only 11
months.
7. ENDOSCOPIC INJECTION
Although controversy remains about the role of endoscopic
injectionforVURasanalternativetoureteralreimplantation
in young children, there are few “reimplanters” who would
completely dismiss this option in patients after puberty.
This technique has been practiced for over 20 years and a
variety of bulking agents have been injected including poly-
tetraﬂuoroethylenepaste,gluteraldehydecross-linkedbovine
collagen, polydimethysiloxane, and detranomer/hyaluronic
acid copolymer (D/HA) [23]. In the United States the D/HA
copolymer is the only agent that has been FDA approved for
use in children. A recent series by Okeke et al. reported 9
women (mean age of 26) with symptomatic VUR associated
with acute pyelonephritis who were treated endoscopically
with D/HA [24]. All were treated successfully with no reﬂux
by VCUGs at 3 months postoperatively, although 1 did
require a second injection for persistent VUR. Two patients
had transient ﬂank pain immediately postoperatively which
resolved after a few days. At a mean follow-up of 14
months, none of the patients had further infections or
symptoms. In children, the treatment of VUR with D/HA
injections has been associated with a lower incidence of
UTIs postoperatively [25]. It is unknown whether or not
postpubertal patients are at the same risk for late failures of
endoscopic injection as was described in some of the original
series of children.
8. LAPAROSCOPIC AND ROBOTIC
URETERAL REIMPLANTATION
Minimally invasive ureteral reimplantation for VUR has
been performed for over a decade; however its widespread
uses have been slow to spread. Proponents of laparoscopic
surgery would cite the limited laparoscopic experience of
most pediatric urologists as a primary factor for this slow
adaptation. However, many would argue against relearning
todoaprocedurewhichhasrapidrecovery,highsuccessrate,
lowcomplicationrate,andisdonethroughaninconspicuous
incision. A low, transverse abdominal incision leaves a scar
that often blends into the natural creases of the abdominal
skin leaving a barely visible mark. If placed low enough
it is covered by undergarments and is not disﬁguring.
Given the questionable beneﬁts and technical diﬃculties the
laparoscopic technique has been slow to gain acceptance.
One population where this approach actually may be a real
asset is in treating VUR after puberty.
Both intra- and extra-vesical laparoscopic techniques for
reimplantation have been described in children [26–28]. In
the postpubertal female, the advantage for laparoscopy is
that the scope and instruments can reach deep into the
pelvis with good visualization. Shu et al. reported a series
of laparoscopic extravesical reimplantations performed for
VUR in postpubertal females at a mean age of 18 [29].
One patient underwent bilateral and the other 5 unilateral
reimplantation. 1 patient had transient ureteral obstruction
requiring a temporary stent placement. All had resolution of
their VUR postoperatively.
Robotic assisted laparoscopic surgery has become a
widely practiced urologic technique for performing radical
prostatectomy [30]. The surgeons utilizing the robot for
prostatectomies tout the increased magniﬁcation, 3D visual-
ization, and precision movements the wristed instruments as
advantages over the open surgical procedure. The neurovas-
cular bundles are well visualized, as is the apical dissection
of the prostate and urethra. Performing deep pelvic surgery
such as ureteral reimplantation in postpubertal patients is a
situation where the robotic approach may have an advantage
over traditional open surgical reimplantation. There are
limited reports of robotic ureteral reimplantations being4 Advances in Urology
performed in children [31]. The robot allows a surgeon
with good open surgical skills to perform complex laparo-
scopic procedures. Extravesical ureteral reimplantation has
been associated with postoperative urinary retention when
performed bilaterally [32]. This is felt to be due to injury
to the pelvic plexus during the dissection of the ureter
extravesically [33]. Casale et al. reported a series of 41
children with a mean age of 33 months treated with bilateral
robotic “nerve-sparing” extravesical reimplantation [34]. All
children voided well after catheter removal on postoperative
day number 1. No patient had retention as documented by
ultrasonic bladder scanning. Reﬂux was cured in 97% and
no ureters were obstructed. If these impressive results can
be achieved by other surgeons and applied to postpubertal
patients, this could become the preferred approach to
ureteral reimplantation surgery after puberty.
9. CONCLUSIONS
The natural history of untreated VUR in postpubertal
patients is unknown. Treatment of VUR should be consid-
ered in those patients with VUR and recurrent febrile UTIs.
The optimal method to treat VUR is not clear. Endoscopic
injection is a minimally invasive approach which has a
good success rate for treating VUR and oﬀers some beneﬁts
over ureteral reimplantation. The role of laparoscopic and
robotic ureteral reimplantation is evolving and may oﬀer
some advantages over open ureteral reimplantation in post-
pubertal patients.
REFERENCES
[1] R. Baker, W. Maxted, J. Maylath, and I. Shulman, “Relation
of age, sex, and infection to reﬂux: data indicating high
spontaneous cure rate in pediatric patients,” The Journal of
Urology, vol. 95, no. 1, pp. 27–32, 1966.
[2] J.A.Hutch,“Vesico-ureteralreﬂuxintheparaplegic:causeand
correction,” The Journal of Urology, vol. 68, no. 2, pp. 457–467,
1952.
[3] J. M. Smellie, “Commentary: management of children with
severe vesicoureteral reﬂux,” The Journal of Urology, vol. 148,
no. 5, part 2, pp. 1676–1678, 1992.
[4] J. M. P. Silva, J. S. S. Diniz, V. S. P. Marino, et al.,
“Clinical course of 735 children and adolescents with primary
vesicoureteral reﬂux,” Pediatric Nephrology, vol. 21, no. 7, pp.
981–988, 2006.
[5] C. S. Cooper, B. I. Chung, A. J. Kirsch, D. A. Canning, and
H. M. Snyder III, “The outcome of stopping prophylactic
antibiotics in older children with vesicoureteral reﬂux,” The
Journal of Urology, vol. 163, no. 1, pp. 269–273, 2000.
[6] R. H. Thompson, J. J. Chen, J. Pugach, S. Naseer, and
G. F. Steinhardt, “Cessation of prophylactic antibiotics for
managing persistent vesicoureteral reﬂux,” The Journal of
Urology, vol. 166, no. 4, pp. 1465–1469, 2001.
[7] S.Yucel,A.Gupta,andW. Snodgrass,“Multivariate analysisof
factors predicting success with dextranomer/hyaluronic acid
injection for vesicoureteral reﬂux,” The Journal of Urology, vol.
177, no. 4, pp. 1505–1509, 2007.
[8] A. J. Kirsch, M. Perez-Brayﬁeld, E. A. Smith, and H. C. Scherz,
“Themodiﬁedstingproceduretocorrectvesicoureteralreﬂux:
improved results with submucosal implantation within the
intramural ureter,” The Journal of Urology, vol. 171, no. 6, part
1, pp. 2413–2416, 2004.
[9] A. Haferkamp, H. Contractor, K. M¨ ohring, G. Staehler, and
J. D¨ orsam, “Failure of subureteral bovine collagen injection
for the endoscopic treatment of primary vesicoureteral reﬂux
in long-term follow-up,” Urology, vol. 55, no. 5, pp. 759–763,
2000.
[10] G. L¨ ackgren, N. W˚ ahlin, E. Sk¨ oldenberg, and A. Stenberg,
“Long-term followup of children treated with dextranomer/
hyaluronic acid copolymer for vesicoureteral reﬂux,” The
Journal of Urology, vol. 166, no. 5, pp. 1887–1892, 2001.
[11] B. Chertin, E. Colhoun, M. Velayudham, and P. Puri, “Endo-
scopic treatment of vesicoureteral reﬂux: 11 to 17 years of
followup,” The Journal of Urology, vol. 167, no. 3, pp. 1443–
1445, 2002.
[12] L. C. Gilstrap III, F. G. Cunningham, and P. J. Whalley,
“Acute pyelonephritis in pregnancy: an anterospective study,”
Obstetrics & Gynecology, vol. 57, no. 4, pp. 409–413, 1981.
[13] J. T. Mansﬁeld, B. W. Snow, P. C. Cartwright, and K.
Wadsworth, “Complications of pregnancy in women after
childhood reimplantation for vesicoureteral reﬂux: an update
with25yearsoffollowup,”TheJournalofUrology,vol.154,no.
2, pp. 787–790, 1995.
[14] R. Beetz, W. Mannhardt, M. Fisch, R. Stein, and J. W. Th¨ uroﬀ,
“Long-termfollowupof158youngadultssurgicallytreatedfor
vesicoureteral reﬂux in childhood: the ongoing risk of urinary
tract infections,” The Journal of Urology, vol. 168, no. 2, pp.
704–707, 2002.
[15] C. D. A. Herndon, M. DeCambre, and P. H. McKenna,
“Changing concepts concerning the management of vesi-
coureteral reﬂux,” The Journal of Urology, vol. 166, no. 4, pp.
1439–1443, 2001.
[16] V. A. Politano and W. F. Leadbetter, “An operative technique
for the correction of vesicoureteral reﬂux,” The Journal of
Urology, vol. 79, no. 6, pp. 932–941, 1958.
[17] E. T. Gonzales, J. F. Glenn, and E. E. Anderson, “Results of
distal tunnel ureteral reimplantation,” The Journal of Urology,
vol. 107, no. 4, pp. 572–575, 1972.
[18] S. J. Cohen, “The Cohen reimplantation technique,” Birth
DefectsOriginalArticleSeries,vol.13,no.5,pp.391–395,1977.
[19] K. A. Burbige, “Ureteral reimplantation: a comparison of
results with the cross-trigonal and politano-leadbetter tech-
niques in 120 patients,” The Journal of Urology, vol. 146, no.
5, pp. 1352–1353, 1991.
[ 2 0 ]S .M a r s h a l l ,T .G u t h r i e ,R .J e ﬀs, V. Politano, and R. P.
Lyon, “Ureterovesicoplasty: selection of patients, incidence
and avoidance of complications. A review of 3,527 cases,” The
Journal of Urology, vol. 118, no. 5, pp. 829–831, 1977.
[21] J. M. Gil-Vernet, “A new technique for surgical correction of
vesicoureteral reﬂux,” The Journal of Urology, vol. 131, no. 3,
pp. 456–458, 1984.
[22] F. S. Aghdas and H. Akhavizadegan, “Gil-vernet anti-reﬂux
surgery and primary vesicoureteral reﬂux in women,” Scan-
dinavian Journal of Urology and Nephrology,v o l .4 1 ,n o .1 ,p p .
72–74, 2007.
[23] J. C. Austin and C. S. Cooper, “Vesicoureteral reﬂux: surgical
approaches,” Urologic Clinics of North America, vol. 31, no. 3,
pp. 543–557, 2004.
[ 2 4 ]Z .O k e k e ,D .F r o m e r ,M .H .K a t z ,E .A .R e i l e y ,a n dT .W .
Hensle, “Endoscopic management of vesicoureteral reﬂux
in women presenting with pyelonephritis,” The Journal of
Urology, vol. 176, no. 5, pp. 2219–2221, 2006.J. Christopher Austin 5
[ 2 5 ]G .M .W a d i e ,M .V .T i r a b a s s i ,R .A .C o u r t n e y ,a n dK .P .
Moriarty, “The deﬂux procedure reduces the incidence of
urinary tract infections in patients with vesicoureteral reﬂux,”
Journal of Laparoendoscopic & Advanced Surgical Techniques,
vol. 17, no. 3, pp. 353–359, 2007.
[26] R. M. Ehrlich, A. Gershman, and G. Fuchs, “Laparoscopic
vesicoureteroplasty in children: initial case reports,” Urology,
vol. 43, no. 2, pp. 255–261, 1994.
[ 2 7 ]I .S .G i l l ,L .E .P o n s k y ,M .D e s a i ,R .K a y ,a n dJ .H .R o s s ,
“Laparoscopic cross-trigonal Cohen ureteroneocystostomy:
novel technique,” The Journal of Urology, vol. 166, no. 5, pp.
1811–1814, 2001.
[28] Y. Lakshmanan and L. C. T. Fung, “Laparoscopic extravesic-
ular ureteral reimplantation for vesicoureteral reﬂux: recent
technical advances,” Journal of Endourology, vol. 14, no. 7, pp.
589–594, 2000.
[29] T. Shu, L. J. Cisek Jr., and R. G. Moore, “Laparoscopic
extravesical reimplantation for postpubertal vesicoureteral
reﬂux,” Journal of Endourology, vol. 18, no. 5, pp. 441–446,
2004.
[30] G. N. Box and T. E. Ahlering, “Robotic radical prostatectomy:
long-term outcomes,” Current Opinion in Urology, vol. 18, no.
2, pp. 173–179, 2008.
[31] C. A. Peters, “Robotically assisted surgery in pediatric urol-
ogy,” Urologic Clinics of North America, vol. 31, no. 4, pp. 743–
752, 2004.
[32] L. C. T. Fung, G. A. McLorie, U. Jain, A. E. Khoury, and B. M.
Churchill, “Voiding eﬃciency after ureteral reimplantation: a
comparison of extravesical and intravesical techniques,” The
Journal of Urology, vol. 153, no. 6, pp. 1972–1975, 1995.
[ 3 3 ]J .L e i s s n e r ,E .P .A l l h o ﬀ,W .W o l ﬀ, et al., “The pelvic plexus
and antireﬂux surgery: topographical ﬁndings and clinical
consequences,” The Journal of Urology, vol. 165, no. 5, pp.
1652–1655, 2001.
[34] P. Casale, R. P. Patel, and T. F. Kolon, “Nerve sparing robotic
extravesical ureteral reimplantation,” The Journal of Urology,
vol. 179, no. 5, pp. 1987–1990, 2008.